Cantab in US vaccines deal
Cantab Pharmaceuticals, the gene and immunotherapy research group, is to develop vaccines against nicotine and cocaine after announcing a deal to buy the treatments from a US company. Cantab is
Cantab Pharmaceuticals, the gene and immunotherapy research group, is to develop vaccines against nicotine and cocaine after announcing a deal to buy the treatments from a US company. Cantab is